KYTX short interest
Kyverna Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 9,618,412 |
|---|---|
| Change vs prior report | 852,078 (+9.7%) |
| Change over six months | +128.3% |
| Days to cover | 8.85 (sector: 3.78) |
| Average daily volume | 1,086,231 |
| Rank in Healthcare | #157 of 922 by days to cover |
KYTX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 9,618,412 | +9.7% | 8.85 | 1,086,231 |
| 2026-09-15 | 8,766,334 | +3.7% | 10.78 | 812,839 |
| 2026-08-31 | 8,454,341 | -0.5% | 12.35 | 684,634 |
| 2026-08-14 | 8,498,858 | +3.9% | 13.34 | 636,888 |
| 2026-07-31 | 8,177,359 | +4.2% | 8.73 | 937,117 |
| 2026-07-15 | 7,846,393 | +8.7% | 6.05 | 1,297,725 |
| 2026-06-30 | 7,218,911 | +18.9% | 4.56 | 1,583,444 |
| 2026-06-15 | 6,069,905 | +5.8% | 8.42 | 720,918 |
| 2026-05-29 | 5,739,106 | +8.6% | 6.85 | 837,754 |
| 2026-05-15 | 5,283,320 | +2.4% | 6.15 | 858,635 |
| 2026-04-30 | 5,161,190 | +22.0% | 2.99 | 1,726,596 |
| 2026-04-15 | 4,231,925 | +0.5% | 6.24 | 678,028 |
| 2026-03-31 | 4,212,602 | +0.2% | 6.16 | 683,757 |
| 2026-03-13 | 4,205,266 | +0.4% | 6.29 | 668,817 |
| 2026-02-27 | 4,189,784 | +6.8% | 9.52 | 439,931 |
| 2026-02-13 | 3,924,276 | +12.0% | 6.01 | 652,823 |
| 2026-01-30 | 3,505,050 | +2.8% | 3.56 | 984,496 |
| 2026-01-15 | 3,408,408 | -4.1% | 3.51 | 972,298 |
| 2025-12-31 | 3,553,051 | +1.8% | 1.18 | 3,004,805 |
| 2025-12-15 | 3,489,945 | -1.1% | 1.63 | 2,137,379 |
| 2025-11-28 | 3,530,429 | +13.5% | 6.36 | 555,489 |
| 2025-11-14 | 3,110,221 | +15.3% | 4.47 | 696,530 |
| 2025-10-31 | 2,696,732 | +71.0% | 3.63 | 741,905 |
| 2025-10-15 | 1,577,306 | +9.0% | 1.48 | 1,068,625 |
| 2025-09-30 | 1,447,317 | -10.0% | 2.36 | 614,237 |
import finzdata as yf
yf.Ticker("KYTX").short_interest # every report since 2017
yf.Client().short_interest(["KYTX"], start="2018-01-01")Healthcare short interest · KYTX price history · Who owns KYTX · All short interest